Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Attends MD&M West Conference in Anaheim

7th Feb 2017 07:00

RNS Number : 1686W
Collagen Solutions PLC
07 February 2017
 

Collagen Solutions Plc

(the "Company" or the "Group")

 

Collagen Solutions at the Medical Design and Manufacturing West Conference in Anaheim 7-9 February

 

Collagen Solutions plc (AIM: COS), the developer and manufacturer of medical grade collagen components for use in regenerative medicine, medical devices and in-vitro diagnostics will have representatives in attendance at the Medical Design and Manufacturing West (MD&M West) conference at the Anaheim Conference Centre in California, USA.

 

For 32 years, MD&M West has helped take medical devices from concept to market by uniting cutting-edge technology with the industry's foremost minds and represents the World's Largest Annual Medtech event.

It connects over 20,000 engineers and executives who are ready and willing to forge business partnerships.

 

Commenting on the MD&D West conference, Jamal Rushdy, CEO of Collagen Solutions said: "MD&M West is an important venue for us to demonstrate and communicate our in-house expertise in medical device development, gain first-hand understanding of what products and services are needed in numerous medical device markets, and further raise the profile of Collagen Solutions as a best-in-class manufacturer and developer of regenerative medicine devices based on our medical grade collagen and tissue technologies. Establishing this awareness is particularly important as we focus on programmes to bring finished devices to the market."

 

About Collagen Solutions:

Collagen Solutions Plc is a global provider of medical grade collagen formulations and components for use in regenerative medicine, medical devices and in-vitro diagnostics and research. The capabilities of the Company include the provision of native, soluble and powdered collagen formulations, processed and semi-processed tissues such as pericardium, bone, and blood vessels, and expertise in the development and contract manufacture of collagen components for use as engineered tissue scaffolds and other medical devices. These products are used in a wide variety of applications including orthopaedics, cardiovascular, dental, plastic surgery, wound healing, neurology and urology. Collagen Solutions' unique offering extends beyond material supply and contract services through the highly skilled staff who support customers through the various stages of development and regulatory approval.

 

For additional information, please visit www.collagensolutions.com.

 

 

Enquiries: 

 

Collagen Solutions Plc

Contact via Walbrook

Jamal Rushdy, Chief Executive Officer

 

Gill Black, Chief Financial Officer

 

 

 

Cenkos Securities plc (Nominated Adviser and Broker)

Stephen Keys

Steve Cox

Tel: 0207 397 8900

 

 

 

 

Walbrook PR

Tel: 020 7933 8780 or [email protected]

Mike Wort

Mob: 07900 608 002

Anna Dunphy

Mob: 07876 741 001

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRAVQLFBDLFEBBV

Related Shares:

COS.L
FTSE 100 Latest
Value8,275.66
Change0.00